ADVERTISEMENT
ADVERTISEMENT
Hims & Hers appoints Anant Vinjamoori as chief medical officer of Hims
In his new role, Vinjamoori will guide clinical strategy across wellness, longevity, preventive and personalized healthcare.
-
Bhavana P - Sat, 20, Jun 2026
- 14:41 EDT
- 71
Anant Vinjamoori / Hims & Hers
California-based digital telehealth platform, Hims & Hers Health, has appointed physician-executive Anant Vinjamoori as chief medical officer of its Hims brand.
Vinjamoori joins the health and wellness platform with more than a decade of experience in internal medicine, primary care and longevity-focused healthcare. In his new role, he will help guide the clinical strategy of the Hims brand across key areas including sexual health, hormone health, dermatology, weight management and mental health. He will also support the company’s expansion into emerging fields such as longevity medicine and peptide therapy.
Also read: Verite Capital Partners names Sumit Majumdar chief sustainability officer
The appointment comes as Hims & Hers continues to broaden its healthcare offerings and invest in proactive, consumer-focused treatment models.
Prior to joining Hims & Hers, Vinjamoori held leadership positions at health technology companies Virta Health and Modern Age, overseeing both medical and product teams. He is also the founder of Next Generation Medicine, an organization that provides medical education and artificial intelligence-driven tools to help clinicians implement evidence-based longevity medicine practices.
Commenting on his new role, Vinjamoori said, “Men are increasingly seeking care that goes beyond reactive treatment – they want to feel their best at every age, and they are paying close attention to the science that makes that possible. This is the right time to increase access to high-quality, science-driven care that helps men feel like the best versions of themselves. Hims has the scale, consumer trust, and vision to do it right. I can’t wait to get started.”
Pat Carroll, global chief medical officer at Hims & Hers, said Vinjamoori’s expertise in preventive and longevity care will help the company bring new treatments, services and research-backed innovations to customers.
Discover more at New India Abroad.
California-based digital telehealth platform, Hims & Hers Health, has appointed physician-executive Anant Vinjamoori as chief medical officer of its Hims brand.
Vinjamoori joins the health and wellness platform with more than a decade of experience in internal medicine, primary care and longevity-focused healthcare. In his new role, he will help guide the clinical strategy of the Hims brand across key areas including sexual health, hormone health, dermatology, weight management and mental health. He will also support the company’s expansion into emerging fields such as longevity medicine and peptide therapy.
Also read: Verite Capital Partners names Sumit Majumdar chief sustainability officer
The appointment comes as Hims & Hers continues to broaden its healthcare offerings and invest in proactive, consumer-focused treatment models.
Prior to joining Hims & Hers, Vinjamoori held leadership positions at health technology companies Virta Health and Modern Age, overseeing both medical and product teams. He is also the founder of Next Generation Medicine, an organization that provides medical education and artificial intelligence-driven tools to help clinicians implement evidence-based longevity medicine practices.
Commenting on his new role, Vinjamoori said, “Men are increasingly seeking care that goes beyond reactive treatment – they want to feel their best at every age, and they are paying close attention to the science that makes that possible. This is the right time to increase access to high-quality, science-driven care that helps men feel like the best versions of themselves. Hims has the scale, consumer trust, and vision to do it right. I can’t wait to get started.”
Pat Carroll, global chief medical officer at Hims & Hers, said Vinjamoori’s expertise in preventive and longevity care will help the company bring new treatments, services and research-backed innovations to customers.
Discover more at New India Abroad.
Related
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login